SEC Form 5 · accession 0001388410-17-000008
PARALLAX HEALTH SCIENCES, INC. · PRLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward W. Withrow Jr.
Director
Period of report
Dec 31, 2015
Accepted (ET)
Jan 18, 2017 · 9:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388410
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPTIONSF1 | $0.05 | Oct 5, 2015 | A | 750,000 | A | — | Oct 5, 2018 | COMMON STOCK | 750,000 | 750,000 | D |
Explanation of responses
- F1187,500 OPTIONS VEST ON DATE OF GRANT, AND 70,313 EVERY 90 DAYS THEREAFTER BEGINNING 01/05/2016 FOR 2 YEARS.
Remarks
ABOVE TRANSACTIONS WERE PREVIOUSLY REPORTED INCORRECTLY ON FORM 3 ON 01/18/2017. AMENDED FORM 3A FILED TO REPORT ACTUAL INITIAL HOLDINGS OF REPORTING PERSON.